News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b Prostate Cancer Clinical Trial Completes Last Visit
September 12, 2025
·
5 min read
Press Releases
BYT Announces Corporate Updates
September 11, 2025
·
3 min read
Press Releases
Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share
September 11, 2025
·
6 min read
Press Releases
Izotropic Gains Visibility as AI Market Broadens Beyond Tech
September 10, 2025
·
4 min read
Press Releases
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
September 10, 2025
·
15 min read
Press Releases
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale
September 10, 2025
·
4 min read
Press Releases
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
September 10, 2025
·
8 min read
Press Releases
PlasCred Circular Innovations Inc. Announces Non-Binding Term Sheet from Business Development Bank of Canada for up to $8.5 Million Building on ERA Grant Support
September 10, 2025
·
7 min read
Press Releases
CellCentric Announces Completion of Enrollment for Dose Optimization Cohorts in Phase 2 Study for Multiple Myeloma
September 9, 2025
·
1 min read
Press Releases
Telo Geonomics Announces Engagement of Investor Relations Service Provider
September 8, 2025
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us